Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.33
-0.26 (-2.24%)
At close: Apr 28, 2026, 4:00 PM EDT
11.34
+0.01 (0.09%)
After-hours: Apr 28, 2026, 7:13 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $899.94 million as of April 28, 2026. Its market cap has increased by 164.82% in one year.
Market Cap
899.94M
Enterprise Value
1.36B
1-Year Change
164.82%
Ranking
Category
Stock Price
$11.33
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $899.94M, an increase of 70.73%. That is a compound annual growth rate of 8.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 974.11M |
| Geron | 961.35M |
| CytomX Therapeutics | 957.85M |
| Annexon | 955.54M |
| Xencor | 951.94M |
| Fortrea Holdings | 916.30M |
| Evommune | 914.15M |
| Janux Therapeutics | 913.08M |